The David H. Koch Institute for Integrative Cancer Research at MIT
Science + Engineering... Conquering Cancer Together
Massachusetts Institute of Technology
National Cancer Institute Cancer Center
Early detection and monitoring is critical to mounting effective cancer treatments. The molecular differences that make cancer cells lethal when left unchecked also provide the clues for their detection, identification and visualization.
As a National Cancer Institute-designated center for four decades, and as one of only seven NCI-designated basic research centers, MIT is at the center of the nation's efforts to conquer cancer.
Visitors to the Koch Institute Public Galleries can explore current cancer research projects, examine striking biomedical images, hear personal reflections on cancer and cancer research and investigate the historical, geographical and scientific contexts out of which the Koch Institute emerged.
These 14 shared biotechnology laboratories provide state-of-the-art tools and specialized expertise to Koch Institute researchers, while also bringing together scientists and engineers to foster interdisciplinary collaboration.
The Koch Institute brings scientists and engineers together to solve the problems of cancer. We have identified five areas of research that we believe are critical for rapid progress toward controlling cancer.
In creating a new era for cancer research, the Koch Institute’s greatest assets are its people. Our world renowned faculty unites leadership in multiple fields of science and engineering with a commitment to truly interdisciplinary collaboration.
The Koch Institute engages public audiences of all ages and backgrounds in current cancer research through a variety of public events, youth outreach programs, and online resources about new cancer solutions.
Learn more about how the White lab is using mass spectrometry to better understand the key components of cell signaling that drive how cancer cells invade and proliferate in glioblastoma.
Engineering the immune system to fight cancer... more
Advancing personalized medicine through analysis of cancer pathways and drug resistance... more
Exploring the molecular and cellular basis of metastasis... more
Creating novel devices for cancer detection and monitoring... more
Developing nanotechnology-based cancer therapeutics... more
With your support, we aim to improve the lives of cancer patients. Our expert cancer biologists and engineers work in tandem to tackle today's most challenging cancer problems and deliver solutions that lead to longer, healthier lives.
Your contributions can make a difference in the fight against cancer. We welcome your help to continue our progress.
The MIT-Harvard Center for Cancer Nanotechnology Excellence is a collaborative effort among MIT, Harvard University, Harvard Medical School, Massachusetts General Hospital, and Brigham and Women's Hospital. more
Watch this animation to learn how the Bhatia lab uses nanomaterials to make tumors more susceptible to treatment. more
Watch this animation to see how a tiny, implantable sensor developed by the Cima lab could enable continuous monitoring of cancer. more
Watch this animation to learn about the Gertler lab's efforts to understand and fight the deadly process of metastasis. more
Watch this animation to learn how the Irvine lab uses nanomaterials-based "cell backpacks" to boost the immune response to cancer. more
Watch this animation to learn how the Vander Heiden lab is working to understand and target cancer metabolism. more
The Bridge Project is a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering and clinical oncology together to solve today’s most challenging problems in cancer research and care.
Join us for a series of evening programs that bring together diverse expert perspectives to discuss emerging cancer solutions.
